The FDA and the IOM report

N Engl J Med. 2007 Dec 13;357(24):2520-1; author reply 2521-2. doi: 10.1056/NEJMc076411.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Drug Approval / legislation & jurisprudence
  • Drug Approval / organization & administration*
  • Drug-Related Side Effects and Adverse Reactions
  • Government Regulation
  • Humans
  • National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division*
  • Risk Assessment
  • United States
  • United States Food and Drug Administration*